Development and validation of simple RP-HPLC-PDA analytical protocol for zileuton assisted with Design of Experiments for robustness determination
Authors:
- Saurabh B. GanorkarSGSaurabh B. Ganorkar
- Dinesh M. DhumalDDDinesh M. Dhumal
- Atul A. ShirkhedkarASAtul A. Shirkhedkar
Open Access
- 1 February 2017
- journal article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 10 (2) , 273-282
Abstract
A simple, rapid, sensitive, robust, stability-indicating RP-HPLC-PDA analytical protocol was developed and validated for the analysis of zileuton racemate in bulk and in tablet formulation. Development of method and resolution of degradation products from forced; hydrolytic (acidic, basic, neutral), oxidative, photolytic (acidic, basic, neutral, solid state) and thermal (dry heat) degradation was achieved on a LC – GC Qualisil BDS C18 column (250mm×4.6mm×5μm) by isocratic mode at ambient temperature, employing a mobile phase methanol and (0.2%, v/v) orthophosphoric acid in ratio of (80:20, v/v) at a flow rate of 1.0mLmin−1 and detection at 260nm. ‘Design of Experiments’ (DOE) employing ‘Central Composite Design’ (CCD) and ‘Response Surface Methodology’ (RSM) were applied as an advancement to traditional ‘One Variable at Time’ (OVAT) approach to evaluate the effects of variations in selected factors (methanol content, flow rate, concentration of orthophosphoric acid) as graphical interpretation for robustness and statistical interpretation was achieved with Multiple Linear Regression (MLR) and ANOVA. The method succeeded over the validation parameters: linearity, precision, accuracy, limit of detection and limit of quantitation, and robustness. The method was applied effectively for analysis of in-house zileuton tabletsKeywords
This publication has 19 references indexed in Scilit:
- Development and Validation of Rapid Resolution RP-HPLC Method for Simultaneous Determination of Atorvastatin and Related Compounds by Use of ChemometricsAnalytical Letters, 2008
- Ruggedness and robustness testingJournal of Chromatography A, 2007
- Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental designTalanta, 2007
- What kind of experimental design for finding and checking robustness of analytical methods?Analytica Chimica Acta, 2005
- Experimental design and optimizationChemometrics and Intelligent Laboratory Systems, 1998
- Sustained-release hydrophilic matrix tablets of zileuton: formulation and in vitro/in vivo studiesJournal of Controlled Release, 1997
- Simultaneous Determination of the 5-Lipoxygenase Inhibitor “Zileuton” and its N-Dehydroxylated Metabolite in Untreated Rat Urine by Micellar Liquid ChromatographyJournal of Liquid Chromatography & Related Technologies, 1996
- Solubility and stability characterization of zileuton in a ternary solvent systemEuropean Journal of Pharmaceutical Sciences, 1996
- Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid ChromatographyClinical Pharmacokinetics, 1995
- 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel diseaseInflammation Research, 1992